Allen D Kline

Title: The Innovations of Allen D Kline

Introduction

Allen D Kline is a notable inventor based in Bargersville, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit platelet aggregation. With a total of 6 patents to his name, Kline's work has had a meaningful impact on medical science.

Latest Patents

Kline's latest patents include innovative compounds that serve as Glycoprotein IIB/IIIA antagonists. These inventions relate to certain bicyclic compounds characterized by a nucleus formed of two fused six-membered rings, such as isoquinoline and tetrahydronaphthalene. These compounds are designed to inhibit platelet aggregation, which is crucial in preventing blood clots. Another significant patent focuses on Glycoprotein IIb/IIIa antagonists, which also involve bicyclic compounds with similar structural features and functionalities.

Career Highlights

Kline is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation and research. His work at Eli Lilly has allowed him to explore and develop groundbreaking solutions in the medical field.

Collaborations

Throughout his career, Kline has collaborated with esteemed colleagues, including Matthew Joseph Fisher and Anne Marie Happ. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Allen D Kline's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence advancements in medical science and improve patient outcomes.